Filing Details
- Accession Number:
- 0000899243-19-002639
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-02-05 16:54:41
- Reporting Period:
- 2017-11-30
- Accepted Time:
- 2019-02-05 16:54:41
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1492674 | T2 Biosystems Inc. | TTOO | Surgical & Medical Instruments & Apparatus (3841) | 204827488 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1615937 | John Mcdonough | 101 Hartwell Avenue Lexington MA 02421 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-11-30 | 47,423 | $0.00 | 406,604 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2018-11-30 | 47,422 | $0.00 | 454,026 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-01-31 | 4,895 | $3.35 | 449,131 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-02-01 | 9,443 | $3.47 | 439,688 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Disposition | 2017-11-30 | 47,423 | $0.00 | 47,423 | $0.00 |
| Common Stock | Restricted Stock Units | Disposition | 2018-11-30 | 47,422 | $0.00 | 47,422 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | M | Direct | ||
| 0 | No | 4 | M | Direct |
Footnotes
- Each restricted stock units ("RSU's") represents a contingent right to receive one share of the Issuer's common stock.
- Includes 567 shares acquired under the Issuer's employee stock purchase plan on November 15, 2018.
- The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $3.32 to $3.39. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $3.34 to $3.55. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- On November 30, 2016 the reporting person was granted 94,845 RSU's that vested in two equal annual installments beginning on November 30, 2017.
Billionaire Hedge Funds
